Literature DB >> 29802021

Sex differences in the outcome after percutaneous coronary intervention - A propensity matching analysis.

Gjin Ndrepepa1, Sebastian Kufner2, Katharina Mayer2, Salvatore Cassese2, Erion Xhepa2, Massimiliano Fusaro2, Endri Hasimi2, Stefanie Schüpke2, Karl-Ludwig Laugwitz3, Heribert Schunkert4, Adnan Kastrati4.   

Abstract

BACKGROUND: Whether there are sex differences in the outcome of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. We undertook this study to assess whether there are sex-related differences in the long-term mortality in a large series of patients with CAD after PCI.
METHODS: The study included 18,334 patients (4735 women and 13,599 men) with CAD treated with PCI. Propensity matching was performed to obtain a group of patients (3000 women and 3000 men) matched for all characteristics available in database. The primary outcome was a composite of cardiac mortality, myocardial infarction or stroke at 3 years of follow-up.
RESULTS: The primary outcome occurred in 660 women and 1440 men (Kaplan-Meier [KM] estimates, 15.2% in women and 11.6% in men, unadjusted hazard ratio [HR] = 1.35, 95% confidence interval [CI] 1.24 to 1.49; P < 0.001). Women were at higher risk of all-cause mortality (15.4% vs. 12.3%; P < 0.001), cardiac mortality (10.2% vs. 7.6%; P < 0.001) and stroke (2.6% vs. 1.4%; P < 0.001) than men. In matched patients, the primary outcome occurred in 371 women and 322 men (KM estimates, 13.4% vs. 11.6%, HR = 1.18 [1.01-1.36], P = 0.033). Women were at higher risk of myocardial infarction (4.2% vs. 3.1%; P = 0.044) but not cardiac (8.7% vs. 8.2%; P = 0.306) or all-cause death (12.5% vs. 12.9%; P = 0.991) or stroke (1.9% vs. 1.6%; P = 0.550) than men.
CONCLUSIONS: After propensity matching, women remained at a higher risk of a composite of cardiac mortality, myocardial infarction or stroke up to 3 years after PCI than men.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Mortality; Percutaneous coronary intervention; Sex

Mesh:

Year:  2018        PMID: 29802021     DOI: 10.1016/j.carrev.2018.05.010

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  5 in total

1.  Impact of gender on in-hospital outcomes in patients with Takotsubo syndrome: A nationwide analysis from 2006 to 2014.

Authors:  Alejandro Lemor; Alvaro J Ramos-Rodriguez; Ricardo De La Villa; Seyed H Hosseini Dehkordi; Fernando Vazquez de Lara; Shawn Lee; Mario Rodriguez Rivera; Abel Casso Dominguez; Edgar Argulian
Journal:  Clin Cardiol       Date:  2018-11-26       Impact factor: 2.882

2.  Sex-related impacts on clinical outcomes after percutaneous coronary intervention.

Authors:  Hyun Woo Park; Seungbong Han; Gyung-Min Park; Soe Hee Ann; Jon Suh; Yong-Giun Kim; Seung-Whan Lee; Young-Hak Kim
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

Review 3.  Animal studies for the evaluation of in situ tissue-engineered vascular grafts - a systematic review, evidence map, and meta-analysis.

Authors:  Suzanne E Koch; Bente J de Kort; Noud Holshuijsen; Hannah F M Brouwer; Dewy C van der Valk; Patricia Y W Dankers; Judith A K R van Luijk; Carlijn R Hooijmans; Rob B M de Vries; Carlijn V C Bouten; Anthal I P M Smits
Journal:  NPJ Regen Med       Date:  2022-02-23

4.  Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: Insights from 6.6 million PCI procedures in the United States.

Authors:  Jessica Potts; Alex Sirker; Sara C Martinez; Martha Gulati; Mirvat Alasnag; Muhammad Rashid; Chun Shing Kwok; Joie Ensor; Danielle L Burke; Richard D Riley; Lene Holmvang; Mamas A Mamas
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

5.  Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry.

Authors:  Christiane Engelbertz; Hans O Pinnschmidt; Eva Freisinger; Holger Reinecke; Boris Schmitz; Manfred Fobker; Roland E Schmieder; Karl Wegscheider; Günter Breithardt; Hermann Pavenstädt; Eva Brand
Journal:  Clin Res Cardiol       Date:  2021-05-26       Impact factor: 5.460

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.